Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Changchun BCHT Biotechnology Co. on 6ix
Earlier from Changchun BCHT Biotechnology
- Announcement on Expected Loss in Performance for 2025
- Announcement on Change of Sponsor Representative for Continuous Supervision
- Announcement on Election of Employee Representative Directors for the 6th Board of Directors
- Announcement on Voluntary Disclosure of Approval of Clinical Trial Application for Adsorbed Acellular DTPa (Dual-component) Combined Vaccine (for Adults and Adolescents)
- Announcement on Making Provisions for Asset Impairment for the First Three Quarters of 2025
Later from Changchun BCHT Biotechnology
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Notice on Convening the 2025 Annual General Meeting
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Jilin Jurisdiction
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Changchun BCHT Biotechnology into a list and get an email when it puts out news.
Follow Changchun BCHT Biotechnology